AtriCure, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
AtriCure, Inc. (ATRC) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) of -$7.50 million for the 12-month period ending 2018-12-31, per its 10-Q filed 2019-10-31.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements · last filed 2019-10-31
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases, (sales), issuances, (settlements) for the quarter ending 2018-12-31 was $0.00.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases, (sales), issuances, (settlements) for the quarter ending 2013-12-31 was $8.03M.
- AtriCure, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases, (sales), issuances, (settlements) for fiscal 2013 was $8.03M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2019-10-31 | -$7.50M 10-Q · filed 2019-10-31 | |
| 2018-09-30 | -$7.50M 10-Q · filed 2018-11-02 | ||
| 2014-12-31 | $0.00 10-Q · filed 2015-07-31 | ||
| 2013-12-31 | $8.03M 10-Q · filed 2014-04-30 | $8.03M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |